{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:21:16Z","timestamp":1790947276596,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T00:00:00Z","timestamp":1346803200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.6061\/clinics\/2012(07)21","type":"journal-article","created":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T10:17:54Z","timestamp":1343038674000},"page":"831-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Clinical pharmacokinetics of vancomycin in the neonate: a review"],"prefix":"10.1016","volume":"67","author":[{"given":"Gian Maria","family":"Pacifici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.6061\/clinics\/2012(07)21_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0146-0005(98)80003-7","article-title":"Neonatal immunology","volume":"22","author":"Schelonka","year":"1998","journal-title":"Semin Perinatol"},{"issue":"suppl 1","key":"10.6061\/clinics\/2012(07)21_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.earlhumdev.2011.01.026","article-title":"Recent advances in prevention of sepsis in the premature neonates in NICU","volume":"87","author":"Manzoni","year":"2011","journal-title":"Early Human Dev"},{"issue":"9730","key":"10.6061\/clinics\/2012(07)21_bib3","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality in 2008: a systematic analysis","volume":"375","author":"Black","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.6061\/clinics\/2012(07)21_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/00003088-200443070-00001","article-title":"Vancomycin pharmacokinetics and administration regimens in neonates","volume":"43","author":"de Hoog","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.6061\/clinics\/2012(07)21_bib5","series-title":"In the Goodman and Gilman's the Pharmacological Basis of Therapeutics","first-page":"1194","article-title":"Protein synthesis inhibitors and miscellaneous and antibacterial agents","author":"Chambers","year":"2006"},{"issue":"2","key":"10.6061\/clinics\/2012(07)21_bib6","first-page":"129","article-title":"Prospective evaluation of a vancomycin dosage guideline for neonates","volume":"10","author":"Gabriel","year":"1991","journal-title":"Clin Pharm"},{"issue":"1","key":"10.6061\/clinics\/2012(07)21_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1442-200X.1997.tb03569.x","article-title":"Pharmacokinetics of antibiotics in neonates","volume":"39","author":"Sato","year":"1997","journal-title":"Acta Paediatr Jpn"},{"key":"10.6061\/clinics\/2012(07)21_bib8","series-title":"Neofax: a manual of drugs used in neonatal care","first-page":"96","article-title":"Antimicrobials","author":"Young","year":"2010"},{"issue":"1","key":"10.6061\/clinics\/2012(07)21_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1179\/acb.2008.003","article-title":"Developmental pharmacology: neonates are not just small adults","volume":"63","author":"Allegaert","year":"2008","journal-title":"Acta Clin Belg"},{"issue":"3","key":"10.6061\/clinics\/2012(07)21_bib10","doi-asserted-by":"crossref","first-page":"F221","DOI":"10.1136\/fn.81.3.F221","article-title":"Pharmacokinetics and dose requirements of vancomycin in neonates","volume":"81","author":"Grimsley","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"9","key":"10.6061\/clinics\/2012(07)21_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/009127000104100901","article-title":"The influences of renal function and maturation on vancomycin elimination in newborns and infants","volume":"41","author":"Capparelli","year":"2001","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"10.6061\/clinics\/2012(07)21_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00007691-199508000-00001","article-title":"Vancomycin pharmacokinetics and dosing in premature neonates","volume":"17","author":"McDougal","year":"1995","journal-title":"Ther Drug Monit"},{"issue":"3","key":"10.6061\/clinics\/2012(07)21_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1203\/00006450-198709000-00024","article-title":"The clinical pharmacology of vancomycin in seriously ill preterm infants","volume":"22","author":"Reed","year":"1987","journal-title":"Pediatr Res"},{"issue":"5","key":"10.6061\/clinics\/2012(07)21_bib14","first-page":"282","article-title":"Vancomycin pharmacokinetics in very low birth weight neonates","volume":"8","author":"Leonard","year":"1989","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.6061\/clinics\/2012(07)21_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1590\/S1807-59322007000400006","article-title":"Vancomycin pharmacokinetics in preterm infants","volume":"62","author":"Machado","year":"2007","journal-title":"Clinics"},{"issue":"1","key":"10.6061\/clinics\/2012(07)21_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/AAC.31.1.52","article-title":"Vancomycin pharmacokinetics and dose recommendations for preterm infants","volume":"31","author":"James","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.6061\/clinics\/2012(07)21_bib17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/01.inf.0000186283.95728.34","article-title":"Vancomycin elimination in human infants with intrauterine growth retardation","volume":"24","author":"Frattarelli","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.6061\/clinics\/2012(07)21_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000480922","article-title":"Vancomycin pharmacokinetics in infants: relationship to postconceptional age and serum creatinine","volume":"14","author":"Kildoo","year":"1990","journal-title":"Dev Pharmacol Ther"},{"issue":"6","key":"10.6061\/clinics\/2012(07)21_bib19","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1128\/AAC.01370-09","article-title":"Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination","volume":"54","author":"Lo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.6061\/clinics\/2012(07)21_bib20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1067\/mcp.2000.105353","article-title":"Vancomycin population pharmacokinetics in neonates","volume":"67","author":"de Hoog","year":"2000","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.6061\/clinics\/2012(07)21_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/clpt.1994.120","article-title":"Population pharmacokinetics of vancomycin in neonates","volume":"56","author":"Seay","year":"1994","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.6061\/clinics\/2012(07)21_bib22","first-page":"713","article-title":"Population pharmacokinetic analysis of vancomycin in neonates","volume":"70","author":"Marqu\u00e9s-Mi\u00f1ana","year":"2010","journal-title":"A new proposal of initial dosage guideline. Br J Clin Pharmacol"},{"issue":"2","key":"10.6061\/clinics\/2012(07)21_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00006454-199302000-00010","article-title":"Individualized pharmacokinetic profiles to compute vancomycin dosage and dosing interval in preterm infants","volume":"12","author":"Jarrett","year":"1993","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.6061\/clinics\/2012(07)21_bib24","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/j.1875-9114.1998.tb03938.x","article-title":"Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation","volume":"18","author":"Buck","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.6061\/clinics\/2012(07)21_bib25","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1128\/AAC.40.5.1139","article-title":"Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation","volume":"40","author":"Amaker","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.6061\/clinics\/2012(07)21_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/106002809302700417","article-title":"Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation","volume":"27","author":"Asbury","year":"1993","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.6061\/clinics\/2012(07)21_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(80)80347-7","article-title":"Clinical pharmacology and efficacy of vancomycin in pediatric patients","volume":"96","author":"Schaad","year":"1980","journal-title":"J Pediatr"},{"issue":"1","key":"10.6061\/clinics\/2012(07)21_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2125.2006.02725.x","article-title":"Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance","volume":"63","author":"Anderson","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.6061\/clinics\/2012(07)21_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/FTD.0b013e31806db3f5","article-title":"Renal drug clearance in preterm neonates: relation to prenatal growth","volume":"29","author":"Allegaert","year":"2007","journal-title":"Ther Drug Monit"},{"issue":"11","key":"10.6061\/clinics\/2012(07)21_bib30","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.2042-7158.1998.tb03342.x","article-title":"The kinetic profile of vancomycin in neonates","volume":"50","author":"Silva","year":"1998","journal-title":"J Pharm Pharmacol"},{"issue":"Suppl 3","key":"10.6061\/clinics\/2012(07)21_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/14767050903180965","article-title":"The impact of ibuprofen or indomethacin on renal drug clearance in neonates","volume":"22","author":"Allegaert","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"10.6061\/clinics\/2012(07)21_bib32","first-page":"331","article-title":"Vancomycin cerebrospinal fluid concentrations after intravenous administration in premature infants","volume":"16","author":"Reiter","year":"1996","journal-title":"J Perinatol"},{"issue":"1","key":"10.6061\/clinics\/2012(07)21_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00006454-198601000-00016","article-title":"Intraventricular vancomycin: observations of tolerance and pharmacokinetics in two infants with ventricular shunt infections","volume":"5","author":"Pau","year":"1986","journal-title":"Pediatr Infect Dis"},{"issue":"2","key":"10.6061\/clinics\/2012(07)21_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005237-200209000-00006","article-title":"Vancomycin and gentamicin in neonates: hindsight, current controversies, and forethought","volume":"16","author":"Dawson","year":"2002","journal-title":"J Perinat Neonatal Nurs"},{"issue":"1","key":"10.6061\/clinics\/2012(07)21_bib35","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1136\/fn.82.1.F1","article-title":"Rationing antibiotic use in neonatal units","volume":"82","author":"Isaacs","year":"2000","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"13","key":"10.6061\/clinics\/2012(07)21_bib36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"10.6061\/clinics\/2012(07)21_bib37","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/INF.0b013e3181906e40","article-title":"Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate","volume":"28","author":"Frymoyer","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.6061\/clinics\/2012(07)21_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/QCO.0b013e328337bb42","article-title":"Understanding pharmacokinetics\/pharmacodynamics in managing neonatal sepsis","volume":"23","author":"Lutsar","year":"2010","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.6061\/clinics\/2012(07)21_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5414\/CPP49247","article-title":"Getting the dose of vancomycin right in the neonate","volume":"49","author":"van den Anker","year":"2011","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"10","key":"10.6061\/clinics\/2012(07)21_bib40","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1128\/JCM.41.10.4660-4665.2003","article-title":"Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri","volume":"41","author":"Center","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.6061\/clinics\/2012(07)21_bib41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5414\/CP201456","article-title":"Pharmacokinetics of vancomycin in neonates admitted to the neonatology unit at the Jordan University Hospital","volume":"49","author":"Badran","year":"2011","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"6","key":"10.6061\/clinics\/2012(07)21_bib42","doi-asserted-by":"crossref","first-page":"F418","DOI":"10.1136\/adc.2007.128280","article-title":"Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule","volume":"93","author":"Plan","year":"2008","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"10.6061\/clinics\/2012(07)21_bib43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2125.1998.00763.x","article-title":"Constant rate infusion of vancomycin in premature neonates: a new dosage schedule","volume":"46","author":"Pawlotsky","year":"1998","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.6061\/clinics\/2012(07)21_bib44","doi-asserted-by":"crossref","first-page":"F365","DOI":"10.1136\/adc.2010.196402","article-title":"Vancomycin prescription in neonates and young infants: towards a simplified dosage","volume":"96","author":"Oudin","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"10.6061\/clinics\/2012(07)21_bib45","first-page":"F233","article-title":"Giving vancomycin as a continuous infusion","volume":"94","author":"Embleton","year":"2009","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"10.6061\/clinics\/2012(07)21_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1179\/joc.2007.19.1.5","article-title":"Antibiotics and antifungals in neonatal intensive care units: a review","volume":"19","author":"Fanos","year":"2007","journal-title":"J Chemother"},{"issue":"2","key":"10.6061\/clinics\/2012(07)21_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jac\/32.2.325","article-title":"Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination","volume":"32","author":"Goetz","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.6061\/clinics\/2012(07)21_bib48","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/jac\/25.4.679","article-title":"Nephrotoxicity of vancomycin, alone and with an aminoglycoside","volume":"25","author":"Rybak","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.6061\/clinics\/2012(07)21_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2165\/00003088-199733010-00004","article-title":"Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children","volume":"33","author":"Rodvold","year":"1997","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.6061\/clinics\/2012(07)21_bib50","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000238512","article-title":"Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy","volume":"33","author":"Nahata","year":"1987","journal-title":"Chemotherapy"},{"issue":"5","key":"10.6061\/clinics\/2012(07)21_bib51","first-page":"278","article-title":"Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children","volume":"8","author":"Goren","year":"1989","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.6061\/clinics\/2012(07)21_bib52","first-page":"103","article-title":"Vancomycin toxicity. What is the evidence for dose dependency","volume":"13","author":"Duffull","year":"1994","journal-title":"Adverse Drug React Toxicol Rev"},{"issue":"1","key":"10.6061\/clinics\/2012(07)21_bib53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00007691-200502000-00012","article-title":"Factors influencing the overestimation of plasma vancomycin concentrations measured by the Abbott TDx technique","volume":"27","author":"Iwamoto","year":"2005","journal-title":"Ther Drug Monit"},{"issue":"10","key":"10.6061\/clinics\/2012(07)21_bib54","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00467-011-1883-0","article-title":"Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates","volume":"26","author":"George","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.6061\/clinics\/2012(07)21_bib55","article-title":"Creatinaemia at birth is equal to maternal creatinaemia at delivery: does this paradigm still hold","author":"Kuppens","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"10.6061\/clinics\/2012(07)21_bib56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2125.2005.02432.x","article-title":"Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation","volume":"60","author":"Mulla","year":"2005","journal-title":"Br J Clin Pharmacol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322201780X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322201780X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-67-7\/cln-67-07-831.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:06:40Z","timestamp":1761721600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S180759322201780X"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322012000700021&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3400177\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S180759322201780X"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2012(07)21","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical pharmacokinetics of vancomycin in the neonate: a review","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2012(07)21","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}